Pharmacies to deliver one-off MenB jab programme for thousands of young people
England’s government will offer a one-off MenB vaccination programme to Year 13 students and under-25 university entrants through community pharmacies, starting late July, following recent outbreaks linked to two deaths and multiple cases. The Joint Committee on Vaccination and Immunisation (JCVI) advised the targeted rollout ahead of the autumn peak in meningococcal B disease among young adults, with eligibility based on age and education status." "article": "England’s government has launched a one-off vaccination programme to protect thousands of young people from meningococcal B (MenB) disease ahead of the next academic year. Eligible individuals include all Year 13 pupils and those under 25 starting university or residential further education, with vaccinations available at participating community pharmacies from late July. The initiative follows outbreaks in Kent, Dorset, and Reading, including two student deaths and 21 confirmed cases in Kent alone, alongside 313 MenB cases in England during 2024/25, which account for 83% of invasive meningococcal disease cases. The programme offers a two-dose vaccination schedule, with the first dose available in July and the second in August. International students under 25 are advised to receive their first dose in their home country if possible. Eligibility extends to those born between 1 September 2007 and 31 August 2008, regardless of education plans, but excludes postgraduate students or those returning to university. The move was recommended by the Joint Committee on Vaccination and Immunisation (JCVI) after assessing the immediate risk to young adults, who face a disproportionate burden of MenB cases. While MenB vaccines are routinely given to infants, current students missed the opportunity unless they received it privately. The JCVI is also reviewing eligibility for routine MenB vaccinations for future updates. The UK Health Security Agency (UKHSA) reported that MenB cases predominantly affect young adults and teenagers, alongside infants already covered by the NHS schedule. The one-off programme aims to mitigate the autumn peak in meningococcal disease, which historically impacts this age group most severely. Appointments for eligible individuals will be coordinated through community pharmacies, expanding access beyond traditional healthcare settings. The government emphasized the urgency of the rollout, given recent outbreaks and the high transmissibility of MenB in close-quadrant environments like universities and colleges.
England’s government has launched a one-off vaccination programme to protect thousands of young people from meningococcal B (MenB) disease ahead of the next academic year. Eligible individuals include all Year 13 pupils and those under 25 starting university or residential further education, with vaccinations available at participating community pharmacies from late July. The initiative follows outbreaks in Kent, Dorset, and Reading, including two student deaths and 21 confirmed cases in Kent alone, alongside 313 MenB cases in England during 2024/25, which account for 83% of invasive meningococcal disease cases. The programme offers a two-dose vaccination schedule, with the first dose available in July and the second in August. International students under 25 are advised to receive their first dose in their home country if possible. Eligibility extends to those born between 1 September 2007 and 31 August 2008, regardless of education plans, but excludes postgraduate students or those returning to university. The move was recommended by the Joint Committee on Vaccination and Immunisation (JCVI) after assessing the immediate risk to young adults, who face a disproportionate burden of MenB cases. While MenB vaccines are routinely given to infants, current students missed the opportunity unless they received it privately. The JCVI is also reviewing eligibility for routine MenB vaccinations for future updates. The UK Health Security Agency (UKHSA) reported that MenB cases predominantly affect young adults and teenagers, alongside infants already covered by the NHS schedule. The one-off programme aims to mitigate the autumn peak in meningococcal disease, which historically impacts this age group most severely. Appointments for eligible individuals will be coordinated through community pharmacies, expanding access beyond traditional healthcare settings. The government emphasized the urgency of the rollout, given recent outbreaks and the high transmissibility of MenB in close-quadrant environments like universities and colleges.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.